Investigating drug-resistant infections in nursing homes
Endemic and Emerging Multidrug Resistant Organisms in Nursing Homes: A Neglected Clinical Setting
This study is looking at how common and serious infections from germs like MRSA and Candida auris are in nursing homes, and it wants to find out which residents might be most at risk so that we can make things safer and healthier for everyone living there.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10868662 on NIH RePORTER |
What this research studies
This research focuses on the prevalence and impact of multidrug-resistant organisms, specifically methicillin-resistant Staphylococcus aureus (MRSA) and Candida auris, in nursing homes. It aims to identify which residents are most at risk for these infections, which are linked to high rates of morbidity and mortality. By collecting data on the carriage and contamination of these pathogens, the study seeks to improve infection control measures in nursing homes. The approach includes assessing the environment and residents to better understand transmission dynamics.
Who could benefit from this research
Good fit: Ideal candidates for this research are nursing home residents, particularly those with a history of antibiotic use or existing health conditions that may increase their risk of infection.
Not a fit: Patients who are not residing in nursing homes or those without risk factors for multidrug-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved infection control practices that reduce the incidence of severe infections in nursing home residents.
How similar studies have performed: Previous research has shown that addressing multidrug-resistant organisms in healthcare settings can lead to significant improvements in patient outcomes, indicating that this approach has potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Gussin, Gabrielle — University of California-Irvine
- Study coordinator: Gussin, Gabrielle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.